Every harvest ends the same way for most growers: the flower goes to the drying rack, the fan leaves go to the compost, the stalk gets chopped, and the root ball — the thing that spent the entire season doing the actual work of building the plant — gets pulled, shaken off, and either binned, burned, or tilled back under. Ask around and you'll find growers who half-suspect there's something in there worth keeping. Old-world hemp and cannabis traditions certainly thought so; root preparations for pain, fever, and joint complaints show up across centuries of folk medicine, long before anyone knew what a cannabinoid receptor was. But without trace THC or CBD to point to, the root has mostly stayed folklore — a thing growers feel is probably useful, without much reason to act on the feeling.
Two studies published in 2025 give that instinct a real foundation. Neither one is about the flower. Both are about the root — one grown conventionally in the field and extracted with ethyl acetate, tested directly in mice and rats dealing with real, induced pain and inflammation; the other grown as lab-cultured adventitious root tissue and extracted with methanol, tested against human dendritic cells and T cells, the immune system's own inflammatory machinery. Different labs, different countries, different extraction chemistry, different biological systems — and yet both landed on the same conclusion from two different directions: the root carries its own independent, non-psychoactive pharmacology, and it's strong enough to measure against real pharmaceutical comparators.
The Root That Kept Mice Alive
The first study, out of Dongguk University's College of Korean Medicine, took dried root from Korean-grown Cannabis sativa, extracted it in 70% ethanol, and fractionated it down to the ethyl acetate layer — the fraction their earlier work had already flagged as the most anti-inflammatory of the bunch. They called it CSREA, and they ran it through three classic pain-and-inflammation models: a formalin injection that produces a sharp early pain response followed by a slower inflammatory one, an acetic-acid "writhing" test used across decades of analgesic research, and a carrageenan-induced paw-swelling model in rats, the standard test for how well something controls acute inflammation.
Mice pre-treated with the higher dose of root extract showed a significantly smaller pain response than untreated mice in both the early, nerve-driven phase and the later, inflammation-driven phase of the formalin test — and in the later phase, it outperformed diclofenac, the pharmaceutical NSAID used as the study's positive control. In the paw-edema model, the root extract suppressed swelling and redness at a level the researchers described as dose-dependent and comparable to diclofenac. But the number that actually stops you mid-scroll is the survival data.
That's not a subtle trend line in a bar graph. That's every animal in the high-dose root-extract group making it through, in a model where every untreated animal did not, and where the standard pharmaceutical treatment saved fewer than half. The researchers were careful to frame this as one dataset from one lab, not a therapeutic claim for humans — and so are we — but it's precisely the kind of result that explains why "the root does something" survived as folk knowledge for this long.
How It Works: The Root Talks to Your Endocannabinoid System
Mechanism is where this gets genuinely interesting for anyone who's been following our endocannabinoid-system coverage. The Dongguk team ran parallel experiments in retinoic-acid-differentiated neuronal cells and found that the root extract was doing something specific: rebalancing the ratio between the two main cannabinoid receptors, CB1 and CB2, back toward a healthier baseline, while simultaneously down-regulating FAAH and MAGL — the two enzymes responsible for breaking down your body's own natural endocannabinoids.
"Less enzyme breaking the signal down means more of your own endocannabinoid tone left standing — the root doesn't add cannabinoids, it protects the ones your body already makes."
The same cells showed something else worth flagging for anyone thinking about neuropathic pain specifically: three genes tied directly to pain signalling — a sodium channel called Nav1.7, an acid-sensing channel called ASIC1A, and a substance-P receptor called TACR1 — were all elevated under the stressed cell state, and all significantly reduced by root extract treatment at the higher dose. This is a root with trace cannabinoid content acting on the exact molecular machinery that determines how much pain a nerve cell transmits in the first place.
The Second Study: Roots Grown in a Lab, Same Underlying Story
The second paper comes from Korea's Research Institute of Bioscience and Biotechnology and takes a completely different route to the root. Instead of digging up field-grown plants, the team induced adventitious roots — a lab-cultured root tissue grown from leaf cuttings under sterile, controlled conditions, a technique already used across the medicinal plant world to produce consistent, reproducible metabolite profiles without the variability of open-field growing. They extracted this lab-grown root tissue three ways — hexane, chloroform, and methanol — and tested each against bone-marrow-derived dendritic cells, the immune system's first responders, and against T cells, the cells dendritic cells activate downstream.
The first finding is one every extractor should sit with: solvent choice wasn't a minor detail, it was the difference between medicine and toxin.
Hexane & Chloroform Extracts
Both induced measurable necrotic and apoptotic cell death in immune cells at concentrations as low as 10 micrograms per millilitre, worsening sharply at higher doses. Where they did suppress inflammatory cytokines, they simultaneously increased IL-1β — the opposite of what you want from an anti-inflammatory.
Methanol Extract
Showed no cytotoxicity at any tested concentration, and delivered broad-spectrum suppression of every inflammatory cytokine measured — including IL-1β, the one the other two solvents couldn't touch — with the effect strengthening as the dose increased.
From there, the methanol root extract kept delivering. Under immune-triggering conditions, it held dendritic cells in an immature, non-inflammatory state — suppressing the surface markers that signal "fully activated," restoring the antigen-uptake ability that normally shuts off once a dendritic cell matures, and reducing the cell's ability to actually present antigens to T cells in the first place.
Root Beat Leaf — In Its Own Study
Why Your Root Zone Now Carries More Weight
This is where the two root studies connect directly back to what we covered a few weeks ago on manure sourcing and heavy metal mobility. Neither of these papers tested how soil practices change root phytochemistry — that link hasn't been measured yet, and we're not going to pretend it has. But the underlying biology makes the connection hard to ignore.
In other words: the soil stewardship this series has been building toward — knowing your manure source, testing compost maturity instead of guessing, favouring cover cropping over aggressive tillage — was always going to matter for flower quality. Now it matters for a second harvestable tissue too, and that tissue is the one organ built specifically to absorb whatever is in the ground beneath it.
What This Means for Your Next Harvest
The Honest Limitations
Both studies were preventative rather than therapeutic in design — the root extract went in before the pain or inflammation was induced, which is standard for early-stage screening but doesn't map directly onto treating pain that's already established. Dosing in the pain study wasn't matched to diclofenac on an equipotent basis, so "on par with" and "outperformed" describe the doses actually tested, not a settled comparison of maximum effectiveness. The mechanism work used a differentiated neuroblastoma cell line, not primary neurons, over a six-hour treatment window. And the adventitious root system in the second study is lab-cultured from leaf tissue under sterile conditions — genetically and metabolically stable by design, but not the same thing as a root pulled from a field-grown plant, so its chemistry may not map one-to-one onto what you'd actually harvest from your own root zone. Group sizes were modest, and researchers in both studies knew which animals or cells received which treatment throughout, so blinding wasn't part of either design.
None of that erases the core finding. Two independent teams, working with different extraction chemistry in different biological systems, both found real, measurable, mechanistically explainable activity in a plant organ most growers have never thought to test. That's not proof the root belongs in your medicine cabinet tomorrow — but it's more than enough reason to stop treating it as waste.
